About Headsafe

Headsafe was established in Sydney, Australia in 2017 by Dr. Adrian Cohen to develop and commercialize the patented NUROCHEK™ system*. Headsafe’s present focus lies in scientific and clinical research into the NUROCHEK system and its application in the assessment of brain function, with research partnerships in the United States, Australia, New Zealand, and the United Kingdom.

*FDA cleared for sale in the United States, not yet available EU or ANZ